Safety and immunogenicity of a modified-vaccinia-virus-Ankara-based influenza A H5N1 vaccine: a randomised, double-blind phase 1/2a clinical trial
Work
Year: 2014
Type: article
Source: The Lancet Infectious Diseases
Authors Joost H. C. M. Kreijtz, Marco Goeijenbier, Fleur M. Moesker, L. Van den Dries, Simone Goeijenbier +10 more
Institutions German Center for Infection Research, Ludwig-Maximilians-Universität München, University of Veterinary Medicine Hannover, Foundation
Cites: 30
Cited by: 89
Related to: 10
FWCI: 8.304
Citation percentile (by year/subfield): 100
Subfield: Epidemiology
Field: Medicine
Domain: Health Sciences
Sustainable Development Goal Good health and well-being
Open Access status: closed